MeiraGTx Holdings plc
NASDAQ:MGTX 4:00:00 PM EDT
| Market Cap (Intraday) | 523.99M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $6.48 |
| 50-Day MA | $6.00 |
| 200-Day MA | $5.99 |
MeiraGTx Holdings plc Stock, NASDAQ:MGTX
450 East 29th Street, 14th floor, New York, New York 10016
United States of America
Phone: +1.646.860.7985
Number of Employees: 381
Description
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on the development and manufacturing of genetic medicines to treat both inherited and more common conditions with severe unmet need. The company was founded on May 1, 2018 and is headquartered in New York, NY.